Gang Luo

2.2k total citations
60 papers, 1.3k citations indexed

About

Gang Luo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Gang Luo has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 13 papers in Pharmacology. Recurrent topics in Gang Luo's work include Pharmacogenetics and Drug Metabolism (8 papers), Traditional Chinese Medicine Analysis (6 papers) and Traditional Chinese Medicine Studies (6 papers). Gang Luo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Traditional Chinese Medicine Analysis (6 papers) and Traditional Chinese Medicine Studies (6 papers). Gang Luo collaborates with scholars based in China, United States and Macao. Gang Luo's co-authors include Xinxin Ding, Donglu Zhang, Chuang Lu, Joyce A. Goldstein, Liang‐Shang Gan, Robert Horowits, Thomas M. Guenthner, Amy Herrera, W. Griffith Humphreys and Sijin Yang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gang Luo

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gang Luo China 17 468 324 176 165 153 60 1.3k
Elizabeth A. Meade United States 12 532 1.1× 250 0.8× 138 0.8× 186 1.1× 18 0.1× 14 2.3k
Shilong Zhong China 23 770 1.6× 144 0.4× 155 0.9× 229 1.4× 8 0.1× 99 1.6k
Chengliang Zhang China 21 425 0.9× 202 0.6× 307 1.7× 32 0.2× 19 0.1× 77 1.4k
Camelia S. Stancu Romania 21 649 1.4× 94 0.3× 86 0.5× 269 1.6× 16 0.1× 58 2.0k
Amir Abbas Momtazi Iran 15 659 1.4× 80 0.2× 165 0.9× 52 0.3× 24 0.2× 17 1.5k
Na‐Young Song South Korea 22 711 1.5× 62 0.2× 238 1.4× 19 0.1× 84 0.5× 59 1.4k
C Fisch France 17 434 0.9× 363 1.1× 140 0.8× 90 0.5× 7 0.0× 33 1.1k
Atul Khandwala United States 17 261 0.6× 102 0.3× 65 0.4× 51 0.3× 115 0.8× 47 892
Huadong Cui United States 16 312 0.7× 274 0.8× 238 1.4× 21 0.1× 9 0.1× 33 1.2k
Fumitoshi Asai Japan 20 308 0.7× 70 0.2× 42 0.2× 994 6.0× 219 1.4× 96 1.9k

Countries citing papers authored by Gang Luo

Since Specialization
Citations

This map shows the geographic impact of Gang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gang Luo more than expected).

Fields of papers citing papers by Gang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gang Luo. The network helps show where Gang Luo may publish in the future.

Co-authorship network of co-authors of Gang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Gang Luo. A scholar is included among the top collaborators of Gang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gang Luo. Gang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yan, Yun, Gang Luo, Xiaowen Liu, et al.. (2025). Mechanical power of ventilation and survival in critically ill obese patients. The American Journal of Emergency Medicine. 93. 160–164. 1 indexed citations
3.
Mazhar, Maryam, et al.. (2024). Myocardial ischemia-reperfusion injury: The balance mechanism between mitophagy and NLRP3 inflammasome. Life Sciences. 355. 122998–122998. 16 indexed citations
4.
Liu, Hao, et al.. (2024). Macrophages after myocardial infarction: Mechanisms for repairing and potential as therapeutic approaches. International Immunopharmacology. 143(Pt 3). 113562–113562. 6 indexed citations
5.
Zhao, Xiaomin, Weijia Liu, Xiaoxi He, et al.. (2024). Hepatocyte growth factor is protective in early stage but bone‐destructive in late stage of experimental periodontitis. Journal of Periodontal Research. 59(3). 565–575. 3 indexed citations
6.
Zhou, Yanan, Hong Wang, Pan Liang, et al.. (2024). Zhilong Huoxue Tongyu capsule protects against atherosclerosis by suppressing EndMT via modulating Hippo/YAP signaling pathway. Journal of Traditional and Complementary Medicine. 14(6). 656–665.
7.
Luo, Gang, et al.. (2024). Biomarcadores Potenciais na Fibrose Miocárdica: Uma Análise Bioinformática. Arquivos Brasileiros de Cardiologia. 121(12). e20230674–e20230674. 1 indexed citations
8.
Li, Ziyi, Mengnan Liu, Mingtai Chen, et al.. (2023). Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 18(5). e0284877–e0284877. 8 indexed citations
9.
Zhou, Yanan, Pan Liang, Jiali Liu, et al.. (2023). Zhilong Huoxue Tongyu capsule alleviates myocardial fibrosis by improving endothelial cell dysfunction. Journal of Traditional and Complementary Medicine. 14(1). 40–54. 2 indexed citations
10.
Luo, Gang, Li Chen, Mingtai Chen, et al.. (2023). Hirudin inhibit the formation of NLRP3 inflammasome in cardiomyocytes via suppressing oxidative stress and activating mitophagy. Heliyon. 10(1). e23077–e23077. 5 indexed citations
11.
Liu, Mengnan, et al.. (2022). Zhilong Huoxue Tongyu Capsule Alleviated the Pyroptosis of Vascular Endothelial Cells Induced by ox-LDL through miR-30b-5p/NLRP3. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 10 indexed citations
12.
Liu, Mengnan, Gang Yuan, Gang Luo, et al.. (2022). Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 16 indexed citations
13.
Liu, Mengnan, et al.. (2022). Danshen decoction in the treatment of heart failure: A systematic review and meta-analysis protocol of randomized controlled trials. Medicine. 101(37). e30698–e30698. 3 indexed citations
14.
Liu, Mengnan, et al.. (2022). Danshen Decoction in the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis Protocol of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2022. 1–6. 5 indexed citations
15.
Liu, Mengnan, Jie Xu, Mingtai Chen, et al.. (2022). Hypertensive heart disease and myocardial fibrosis: How traditional Chinese medicine can help addressing unmet therapeutical needs. Pharmacological Research. 185. 106515–106515. 18 indexed citations
16.
Xu, Tiantian, et al.. (2021). Untargeted and targeted gingival metabolome in rodents reveal metabolic links between high‐fat diet‐induced obesity and periodontitis. Journal Of Clinical Periodontology. 48(8). 1137–1148. 11 indexed citations
17.
Yan, Liting, Xiaoxi He, Yinghua Tang, et al.. (2021). HGF can reduce accumulation of inflammation and regulate glucose homeostasis in T2D mice. Journal of Physiology and Biochemistry. 77(4). 613–624. 4 indexed citations
18.
Xiong, Xiaoqin, et al.. (2020). Is oral lichen planus a risk factor for peri-implant diseases? A systematic review and meta-analysis. BMC Oral Health. 20(1). 150–150. 6 indexed citations
19.
20.
Brouwer, Kenneth R., Stephen Ferguson, Yurong Lai, et al.. (2016). The Importance of In Vitro Liver Models: Experts Discuss Whole-Cell Systems, Transporter Function, and the Best Models for Future In Vitro Testing. 2(1). 1–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth A. Meade Breakdown of academic impact, for papers by Shilong Zhong Breakdown of academic impact, for papers by Chengliang Zhang Breakdown of academic impact, for papers by Camelia S. Stancu Breakdown of academic impact, for papers by Amir Abbas Momtazi Breakdown of academic impact, for papers by Na‐Young Song Breakdown of academic impact, for papers by C Fisch Breakdown of academic impact, for papers by Atul Khandwala Breakdown of academic impact, for papers by Huadong Cui Breakdown of academic impact, for papers by Fumitoshi Asai
Rankless by CCL
2026